Chiron Corp. announced on Monday that it has establishedChiron Mimotopes U.S. (CMUS) to market custom peptides andmultipeptide synthesis kits and related products. CMUS is anaffiliate of Chiron Mimotopes Pty Ltd. of Australia, whichChiron acquired in 1991.
Chiron Mimotopes Pty's proprietary Multipin Peptide Synthesistechnology synthesizes custom peptides at a variety of puritylevels and lengths.
(c) 1997 American Health Consultants. All rights reserved.